Cargando…
Activation of tyrosine kinases by mutation of the gatekeeper threonine
Protein kinases targeted by small-molecule inhibitors develop resistance through mutation of the ‘gatekeeper’ threonine residue of the active site. Here we show that the gatekeeper mutation in the cellular forms of c-ABL, c-SRC, platelet-derived growth factor receptor-α and -β, and epidermal growth...
Autores principales: | Azam, Mohammad, Seeliger, Markus A, Gray, Nathanael S, Kuriyan, John, Daley, George Q |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575426/ https://www.ncbi.nlm.nih.gov/pubmed/18794843 http://dx.doi.org/10.1038/nsmb.1486 |
Ejemplares similares
-
Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state
por: Besch, Alida, et al.
Publicado: (2023) -
Evolutionary divergence in the conformational landscapes of tyrosine vs serine/threonine kinases
por: Gizzio, Joan, et al.
Publicado: (2022) -
Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer
por: Xie, Yuan, et al.
Publicado: (2017) -
Cross-phosphorylation of bacterial serine/threonine and tyrosine protein kinases on key regulatory residues
por: Shi, Lei, et al.
Publicado: (2014) -
Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer
por: Hu, Liang, et al.
Publicado: (2015)